Synergistic ROS generation and directional overloading of endogenous calcium induce mitochondrial dysfunction in living cells

Copyright © 2023 Elsevier Ltd. All rights reserved..

Taking advantage of endogenous Ca2+ to upregulate intramitochondrial Ca2+ level has become a powerful mean for mitochondrial dysfunction-mediated tumor therapy. However, the Ca2+ entered into mitochondria is limited ascribing to the uncontrollability and non-selectivity of endogenous Ca2+ transport. It remains a great challenge to make the maximum use of endogenous Ca2+ to ensure sufficient Ca2+ overloading in mitochondria. Herein, we smartly fabricate an intracellular Ca2+ directional transport channel to selectively transport endogenous Ca2+ from endoplasmic reticulum (ER) to mitochondria based on cascade release nanoplatform ABT-199liposomes/doxorubicin@FeIII-tannic acid (ABT@Lip/DOX@Fe-TA). In tumor acidic microenvironment, Fe3+ ions are firstly released and reduced by tannic acid (TA) to Fe2+ for ROS generation. Subsequently, under the NIR light irradiation, the released ABT-199 molecules combine with ROS contribute to the formation of IP3R-Grp75-VDAC1 channel between ER and mitochondria, thus Ca2+ ions are directionally delivered and intramitochondrial Ca2+ level is significantly upregulated. The synergetic ROS generation and mitochondrial Ca2+ overloading effectively intensifies mitochondrial dysfunction, thereby achieving efficient tumor inhibition. This work presents a new insight and promising avenue for endogenous Ca2+-involved tumor therapies.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:301

Enthalten in:

Biomaterials - 301(2023) vom: 15. Okt., Seite 122284

Sprache:

Englisch

Beteiligte Personen:

Shao, Fengying [VerfasserIn]
Han, Jianyu [VerfasserIn]
Tian, Zhaoyan [VerfasserIn]
Wang, Zhi [VerfasserIn]
Liu, Songqin [VerfasserIn]
Wu, Yafeng [VerfasserIn]

Links:

Volltext

Themen:

80168379AG
Ca(2+) directional transport
Calcium
Cascade release
Doxorubicin
Ferric Compounds
Journal Article
Mitochondrial Ca(2+) overloading
N54AIC43PW
ROS
Reactive Oxygen Species
Research Support, Non-U.S. Gov't
SY7Q814VUP
Tumor therapy
Venetoclax

Anmerkungen:

Date Completed 06.09.2023

Date Revised 12.09.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.biomaterials.2023.122284

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM361175973